Literature DB >> 31446997

Premalignant lesions of squamous cell carcinoma of the lung: The molecular make-up and factors affecting their progression.

Evgeny V Denisov1, Anastasia A Schegoleva2, Polina A Gervas2, Anastasia A Ponomaryova2, Lubov A Tashireva3, Valentina V Boyarko4, Ekaterina B Bukreeva4, Olga V Pankova3, Vladimir M Perelmuter3.   

Abstract

Squamous cell carcinoma (SCC), one of the most common forms of lung cancer, shows accelerated progression and aggressive growth and usually is observed at advanced stages. SCC originates from morphological changes in the bronchial epithelium that occur during chronic inflammation: basal cell hyperplasia, squamous metaplasia, and dysplasia I-III. However, the process is not inevitable; it can be stopped at any stage, remain in the stable state indefinitely and either progress or regress. The reasons and mechanisms of different scenarios of the evolution of premalignant lesions in the respiratory epithelium are not fully understood. In this review, we summarized the literature data (including our own data) regarding genetic, epigenetic, transcriptomic and proteomic profiles of the premalignant lesions and highlighted factors (environmental causes, inflammation, and gene polymorphism) that may govern their progression or regression. In conclusion, we reviewed strategies for lung cancer prevention and proposed new models and research directions for studying premalignant lesions and developing new tools to predict the risk of their malignant transformation.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Basal cell hyperplasia; Dysplasia; Premalignant lesion; Progression; Squamous cell lung carcinoma; Squamous metaplasia

Mesh:

Year:  2019        PMID: 31446997     DOI: 10.1016/j.lungcan.2019.07.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  8 in total

1.  Is sputum cytology reliable for detection of atypical lung epithelial proliferative changes triggered by cigarette smoking?

Authors:  Hussain Gadelkarim Ahmed; Emad Abboh Abdallah Abboh; Alfatih Mohamed Ahmed Alnajib; Gamal Eldin Mohamed Osman Elhussein; Naif K Binsaleh; Saadalnour Abusail Mustafa; Rania Abdeen Hussain Abdalla; Ali Yousef Yahia Babiker; Mohammed Siddig AbdElaziz Mohammed
Journal:  Int J Clin Exp Pathol       Date:  2021-05-15

2.  LncRNA PITPNA-AS1/miR-223-3p/PTN axis regulates malignant progression and stemness in lung squamous cell carcinoma.

Authors:  Bi-Hao Peng; Yu-Fei Ji; Xiao-Jian Qiu
Journal:  J Clin Lab Anal       Date:  2022-05-19       Impact factor: 3.124

3.  Identification of a prognostic long noncoding RNA signature in lung squamous cell carcinoma: a population-based study with a mean follow-up of 3.5 years.

Authors:  Rongjiong Zheng; Mengdi Zheng; Mingming Wang; Feijie Lu; Meiling Hu
Journal:  Arch Public Health       Date:  2021-04-28

4.  NTCU induced pre-malignant and malignant stages of lung squamous cell carcinoma in mice model.

Authors:  Muhammad Asyaari Zakaria; Nor Fadilah Rajab; Eng Wee Chua; Gayathri Thevi Selvarajah; Siti Fathiah Masre
Journal:  Sci Rep       Date:  2021-11-18       Impact factor: 4.379

5.  Core genes involved in the regulation of acute lung injury and their association with COVID-19 and tumor progression: A bioinformatics and experimental study.

Authors:  Aleksandra V Sen'kova; Innokenty A Savin; Evgenyi V Brenner; Marina A Zenkova; Andrey V Markov
Journal:  PLoS One       Date:  2021-11-22       Impact factor: 3.240

6.  Comparison of tumor and two types of paratumoral tissues highlighted epigenetic regulation of transcription during field cancerization in non-small cell lung cancer.

Authors:  Qiushi Wang; Libo Wu; Jiaxing Yu; Guanghua Li; Pengfei Zhang; Haozhe Wang; Lin Shao; Jinying Liu; Weixi Shen
Journal:  BMC Med Genomics       Date:  2022-03-21       Impact factor: 3.063

7.  Total mutational load and clinical features as predictors of the metastatic status in lung adenocarcinoma and squamous cell carcinoma patients.

Authors:  Karen Y Oróstica; Juan Saez-Hidalgo; Pamela R de Santiago; Solange Rivas; Sebastian Contreras; Gonzalo Navarro; Juan A Asenjo; Álvaro Olivera-Nappa; Ricardo Armisén
Journal:  J Transl Med       Date:  2022-08-18       Impact factor: 8.440

8.  Neoadjuvant chemotherapy combined with intraoperative radiotherapy is effective to prevent recurrence in high-risk non-small cell lung cancer (NSCLC) patients.

Authors:  Olga V Pankova; Evgeny O Rodionov; Sergey V Miller; Sergey A Tuzikov; Liubov A Tashireva; Tatiana S Gerashchenko; Evgeny V Denisov; Vladimir M Perelmuter
Journal:  Transl Lung Cancer Res       Date:  2020-08
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.